共 121 条
[1]
Abu-Shakra M(1995)Mortality in systemic sclerosis: a comparison with the general population J Rheumatol 22 2100-2102
[2]
Lee P(2015)Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry Semin Arthritis Rheum 45 309-314
[3]
Hinchcliff M(2014)Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study Ann Rheum Dis 73 1340-1349
[4]
Khanna S(1990)Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography Radiology 176 755-759
[5]
Hsu VM(2011)Interstitial lung disease in systemic sclerosis Autoimmun Rev 10 248-255
[6]
Lee J(2017)Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension Arthritis Res Ther 19 122-1093
[7]
Almagor O(2003)Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach Ann Rheum Dis 62 1088-2405
[8]
Chang RW(2003)Scleroderma patients with combined pulmonary hypertension and interstitial lung disease J Rheumatol 30 2398-191
[9]
Coghlan JG(2006)Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease Arthritis Rheum 54 184-577
[10]
Denton CP(2022)Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension Sci Rep 12 5289-1024